May 13, 2013
Callidus Biopharma Announces $ 4 .6 million in Series A Financing to Pursue Orphan Disease Therapies
DOYLESTOWN, PA (May 13, 2013)–Callidus Biopharma, Inc., a development-stage biotechnologycompany focused on creating breakthrough biologic drugs for a range of
San Rafael, Calif, March 19, 2013 – BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today results from POM-001, the Phase 1/2
February 16, 2013
2013 PCMA of Texas’s Pull for Pompe set for April 20, 2013!
The PCMA of Texas invites you to enjoy a day of family fun benefitting Acid Maltase Deficiency, also known as
January 5, 2013
2012 AMDA Research Grant Awarded
The AMDA is excited to announce that the 2012 AMDA Research Grant Recipient is Dr. Nuno Raimundo of the University
CRANBURY, NJ, January 4, 2013 – Amicus Therapeutics today announced positive preliminary results from all 4 dose cohorts in a